Global 3D Bioprinting Market Outlook
The 3D bioprinting market was estimated at a market size of USD 0.460 billion in 2016 and is set to be valued at USD 1.3 billion by the end of forecast period i.e. 2024. Moreover, the growing market size is anticipated to be achieved at the CAGR of 13.8% during the forecast period i.e. 2016-2024. In the 3D bioprinting sector, San Francisco based Prellis Biologics has raised USD 1.8million for the development of microvasculature 3D printing tech for human organ printing.
Market Overview
According to Goldstein Research, the global 3D bioprinting market is segmented based on technology, applications, and geography. Based on geography, North America and Europe together dominate the global 3D bioprinting market with approximately 60.0% market share in 2016. However, it is anticipated that Asia Pacific region tends to take lead in 3D bioprinting technology in future. Asia Pacific region is considered as one of the prime regions in terms of potential adoption of 3D bioprinting technology, dominated by South Korea, Japan, and China, which currently contributes nearly 20.0% share in global 3D bioprinting market.
Browse Full Report: 3D Bioprinting Market
. As per the research analysis, in the U.K. a kidney transplant patient has to wait on an average for 944 days. The similar or much worse waiting situation is analyzed for the liver. Lungs and other organs. In the United States this shortfall of organs for transplant has led to nearly 900,000 deaths per years or in other words it accounts for one-third of all deaths in the U.S. With the advancing technology in 3D bioprinters Market Across the world, the huge shortage of organs for lifesaving transplant is one of the key factor driving the of bioprinting, the shortage of organs could be eliminated & prevent or delayed the death incidences.
3D BioPrinting Market Segmentation
By Technology
- Inkjet-Based Bio Printing
- Extrusion Based Bio Printing
- Laser-Based Bio Printing
By Applications
- Pharmaceuticals
- Tissue and Organ Regeneration
- Bones
- 3D Cell Culture
- other
By Geography
- North America (US, Canada) 3D BioprintingMarket {Market Share (%), Market Size (USD Billion), Adoption Rate (%)}
- Europe (UK, France, Italy, Germany, Spain, Hungary, Sweden, Russia, Poland and Rest of Europe) 3D BioprintingMarket {Market Share (%), Market Size (USD Billion), Adoption Rate (%)}
- The Middle East and Africa (GCC Countries, North Africa, South Africa and Rest of the Middle East & Africa) 3D BioprintingMarket {Market Share (%), Market Size (USD Billion), Adoption Rate (%)}
- Latin America (Brazil, Mexico and Rest of Latin America) 3D BioprintingMarket {Market Share (%), Market Size (USD Billion), Adoption Rate (%)}
- Asia Pacific (China, Japan, India, Singapore, South Korea, Australia, New Zealand and Rest of Asia-Pacific) 3D BioprintingMarket {Market Share (%), Market Size (USD Billion), Adoption Rate (%)}
Major Players Included in the 3D Bio Printing Market are: Organavo, BioBots, Cellink, Poietis, EnvisionTecGmbh, Nano3D Biosciences Inc., Cyfuse Biomedical, 3D Biotek LLC, RegenHU ltd., Insphero, GeSim.
Trend: 3D Bioprinting Attracts Investors
BIOLIFE4D, a medical technology manufacturer in USA has registered a USD 50 million initial public offering with the SEC under Regulation A+ rules and signed a laboratory service agreement with Northwestern University in order to access world-class academic research facilities and resources, including sophisticated imaging and instrumentation capabilities to make the technology faultless in order to fabricate viable organ replacement a safe, accessible and affordable reality.
Shortage of Organs and Rising Need for Transplants Driving the Market
According to World Health Organization (WHO) more than 119,873 organs were transplanted which is increasing by 1.81% annually. Shortage of organs and rising need for transplants has significantly bolstered the demand for 3D bio-printed organs to overcome the shortage of organs for transplants.
Challenge: Huge Investments at Nascent Stage of 3D Bioprinting
However, being in its nascent stage huge investments and high cost of devices hinders the growth of 3d bioprinting market. But, once 3D Bioprinting of human tissues and organs become commercially feasible, patients will have access to these organs, printed using the size and organic structure they need. As healthcare cost drops, these innovation will play an important role for both emerging and developed economies.
Global 3D Bioprinting Market Outlook, 2016-2024 Covers:
- Forecast market size (USD), market share (%) and market growth CAGR, 2016-2024
- Present ground scenario and future opportunity prospects for the market players to analyze the target markets across the globe.
- In-depth competitive analysis of the major players and leaders in the healthcare industry.
- Future prospects of the overall healthcare industry based on manufacturers, suppliers, distributors, pharmaceutical & biotechnology companies, cosmetic product manufacturers, healthcare institutions, clinical centers, medical research laboratories, and academic medical centers and universities.
- The report also includes Porter’s five force model, SWOT analysis, company profiling, business strategies of market players and their business models.
- Global 3D bioprinting market report also recognizes value chain analysis to understand the cost differentiation to provide a competitive advantage to the existing and new entry players.
- Market growth dynamics, challenges, risk analysis, trends & opportunities for the new & existing players in the market.
- The market segmentation in the report is backed by the estimated & forecast market size (USD) & market share (%) along with the BPS analysis & market attractiveness.
Browse More Similar Report Published By Goldstein Research